G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $704,121 | -51.2% | 308,825 | -7.6% | 0.00% | -33.3% |
Q1 2024 | $1,443,446 | +192.0% | 334,131 | +106.2% | 0.00% | +200.0% |
Q4 2023 | $494,292 | +279.7% | 162,063 | +79.3% | 0.00% | – |
Q3 2023 | $130,176 | -53.2% | 90,400 | -12.9% | 0.00% | -100.0% |
Q1 2023 | $278,138 | -87.3% | 103,783 | -74.3% | 0.00% | -85.7% |
Q4 2022 | $2,189,935 | -33.1% | 403,303 | +53.8% | 0.01% | -36.4% |
Q3 2022 | $3,275,000 | +492.2% | 262,182 | +134.2% | 0.01% | +450.0% |
Q2 2022 | $553,000 | +203.8% | 111,932 | +368.6% | 0.00% | +100.0% |
Q1 2022 | $182,000 | -86.9% | 23,885 | -82.5% | 0.00% | -66.7% |
Q4 2021 | $1,391,000 | +22.3% | 136,235 | +60.8% | 0.00% | 0.0% |
Q3 2021 | $1,137,000 | -91.7% | 84,731 | -86.5% | 0.00% | -90.3% |
Q2 2021 | $13,729,000 | -31.8% | 625,754 | -25.3% | 0.03% | -40.4% |
Q1 2021 | $20,145,000 | +296.4% | 837,276 | +196.4% | 0.05% | +246.7% |
Q4 2020 | $5,082,000 | +169.5% | 282,475 | +73.0% | 0.02% | +114.3% |
Q3 2020 | $1,886,000 | +41.4% | 163,310 | +34.9% | 0.01% | -36.4% |
Q1 2020 | $1,334,000 | -24.5% | 121,049 | +81.0% | 0.01% | +120.0% |
Q4 2019 | $1,767,000 | +582.2% | 66,871 | +487.6% | 0.01% | +400.0% |
Q3 2019 | $259,000 | -87.9% | 11,380 | -91.2% | 0.00% | -85.7% |
Q1 2019 | $2,148,000 | +47.8% | 129,420 | +70.6% | 0.01% | +16.7% |
Q4 2018 | $1,453,000 | -7.3% | 75,857 | +79.3% | 0.01% | +20.0% |
Q1 2018 | $1,567,000 | +217.8% | 42,305 | +70.1% | 0.01% | +150.0% |
Q4 2017 | $493,000 | – | 24,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |